European Medical Contract Manufacturing

What European Medical Contract Manufacturing does

European Medical Contract Manufacturing B.V. (EMCM) is a privately held Dutch contract manufacturer founded in 1993 and headquartered in Nijmegen, Netherlands. The company provides full-service development and manufacturing of sterile medicinal products and medical devices for pharmaceutical, biomaterials, and tissue engineering customers. With approximately 100 employees and over 2,000 m2 of GMP-accredited cleanroom space (Class D through Class A / ISO 6 through ISO 5), EMCM operates aseptic fill-finish lines for ampoules, syringes, vials and pouches, alongside powder mixing, packaging, warehousing and global distribution services.

EMCM's core technology stack centres on qualified aseptic processing, a Zirbus freeze dryer with 40 kg/hour condenser capacity, a broad sterilisation offering (steam, gamma, x-ray, beta, ethylene-oxide, and supercritical CO2), and the proprietary eCOO® platform, which uses supercritical carbon dioxide to clean, sterilise and impregnate animal-derived tissues. The company also operates a dedicated, segregated hormone processing facility built in collaboration with Osteo-Pharma. Its proprietary product portfolio — C-Ment® bone cements, Vebroplast® vertebroplasty cement, C-Plug® resorbable cement restrictors, and Adcon® anti-adhesive gel — carries valid CE marks and has been on the European market for over a decade. NovoMem, an acellular resorbable collagen membrane, is in co-development with Leader Biomedical for US FDA 510(k) registration.

Commercially, EMCM runs a B2B enterprise model: services are quote-based per project with pricing negotiated individually, and customer acquisition is driven through industry events (CPHI Barcelona 2023, CPHI Milan 2024), direct sales, and the corporate website. Revenue is generated primarily from contract manufacturing fees across pharmaceuticals, biomaterials and tissue engineering, supplemented by sales of the company's own CE-marked medical devices. Certifications include EN ISO 13485:2016, ISO 9001:2015, an EMA-issued GMP Licence and a Dutch Tissue Licence, supporting regulatory submissions across EMA, USFDA and other jurisdictions.

Name

European Medical Contract Manufacturing

Legal name

European Medical Contract Manufacturing B.V.

Website

https://emcm.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Short description

European Medical Contract Manufacturing (EMCM) is a Netherlands-based B2B contract manufacturer, founded in 1993, providing aseptic fill-finish, freeze drying, sterilisation, packaging, warehousing and tissue processing under GMP and ISO 13485 for pharmaceutical, biomaterials and medical device customers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112), Scientific Research and Development Services (5417)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

akta.pro secondary industries

Rigid Pharmaceutical & Healthcare Plastic Packaging (Pill Bottles, Vials, Med-Grade Jars) (IMALAAAE), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB), Pharmaceutical Labels & Patient Information Packaging (Labels, IFUs, Booklets) (IMALAIAK), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ), Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features) (IMALAIAJ)

Keywords

• Pharmaceutical contract manufacturing
• Sterile fill-finish services
• Aseptic manufacturing services
• Lyophilisation services
• Medical device contract manufacturing

Headquarters

HQ city

Nijmegen

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Others

Revenue model

1. Contract Manufacturing Services: Full-service contract manufacturing providing end-to-end solutions from product development through regulatory affairs, purchasing, manufacturing, final packaging, warehousing and distribution. Serves pharmaceutical, biomaterials, and tissue engineering markets with both aseptic and non-aseptic production capabilities.
2. Proprietary Medical Products: EMCM manufactures and distributes proprietary medical devices including bone cements (C-Ment® Line, Vebroplast®), cement restrictors (C-Plug®), and anti-adhesive gels (Adcon® gel) for orthopaedic and spinal procedures.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

European Medical Contract Manufacturing (EMCM) is a B2B contract manufacturer specializing in aseptic manufacturing of sterile liquid, suspension, gel, and powder medicinal products for pharmaceutical, medical device, biomaterials, and tissue engineering markets. Services include ampoule, vial, syringe, pouch, and powder filling; lyophilisation; sterilisation; packaging; GMP warehousing and logistics; and R&D, tech transfer, and validation. EMCM also develops and supplies proprietary medical devices, including the C-Ment line, Vebroplast, C-Plug, and Adcon gel, and licenses its proprietary eCOO Technology for supercritical CO2 polymer processing.

Product overview

European Medical Contract Manufacturing (EMCM) operates as a full-service contract manufacturer offering a unified portfolio of pharmaceutical and medical device manufacturing services. The core offering encompasses development and manufacturing of sterile medicinal products including liquids, suspensions, gels, and powders for ampoules, vials, pre-filled syringes, pouches, bottles and blisters. EMCM's proprietary medical device portfolio includes C-Ment® Line (bone cements for Hip and Knee Arthroplasty), Vebroplast® (Vertebroplasty bone cement), C-Plug® (resorbable cement restrictor), and Adcon® gel (anti-adhesive scar prevention gel), all bearing valid CE marks. Manufacturing capabilities are supported by in-house technologies including freeze-drying/lyophilisation, multiple sterilisation methods (steam, gamma, x-ray, beta-radiation, Ethylene-oxide, and supercritical CO2), advanced packaging services (blister, pouch, labeling, UDI), GMP warehousing with temperature control, and comprehensive R&D/tech transfer/validation services. The company also developed the proprietary eCOO® Technology platform using supercritical carbon dioxide for tissue processing.

Differentiator

Problem solved

Functional benefit

Brands

• C-Ment® Line: Bone cements for Hip and Knee Arthroplasty procedures
• Vebroplast®
• C-Plug®
• Adcon® gel
• NovoMem
• eCOO® Technology

Products and services

• Contract Manufacturing Services (Sterile Liquids, Suspensions, Gels, Powders) Aseptic B2B contract manufacturing of sterile liquid, suspension, gel, and powder medicinal products, including ampoule, vial, syringe, pouch, and powder filling under GMP, for pharmaceutical and biotechnology clients.
• Freeze-Drying (Lyophilisation) Services Lyophilisation processing of sterile pharmaceutical and biotech products, offered as a service to drug developers and CDMO partners requiring cold-chain-stable sterile dosage forms.
• Sterilisation Services Contract sterilisation processing for medical and pharmaceutical products, supporting multiple sterilisation modalities as applicable to client products.
• Packaging Services Pharmaceutical-grade primary and secondary packaging services for sterile medicinal products, offered as a stand-alone service to clients requiring GMP-compliant packaging.
• Warehousing & Logistics Services GMP-licensed warehousing and logistics services, providing storage and distribution of pharmaceutical and biomaterial products under controlled conditions.
• R&D, Tech Transfer and Validation Services Process development, technology transfer, and validation services supporting client projects from formulation through commercial-scale GMP manufacturing.
• Hormone Processing Facility Dedicated, segregated facility within the Nijmegen site for contract manufacturing of sterile hormone-containing drug products, providing the regulatory and containment segregation that hormone APIs require.
• eCOO Technology Proprietary supercritical CO2 polymer-processing platform for producing biocompatible scaffolds and drug-delivery matrices, offered as a standalone technology to biomaterials and tissue engineering clients.
• C-Ment Line Proprietary branded product line of cement/biomaterial products manufactured by EMCM using its eCOO Technology, sold into the medical and surgical markets.
• Vebroplast Proprietary branded biomaterial/plastic product in EMCM's medical product portfolio.
• C-Plug Proprietary branded medical device plug product in EMCM's medical product portfolio.
• Adcon gel Proprietary branded gel product in EMCM's medical product portfolio, used in surgical applications.

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Osteo-PharmacoreStrategic or Co-development Partner · 21 September 2018Collaboration on dedicated hormone processing facility at EMCM. The facility is segregated from the main cleanroom complex with separate entrance, dedicated air handling system suited for high-potency drugs, and HEPA-filtered emissions. EMCM impregnates (spray-coats) eCOO® processed membranes with pharmaceutical active ingredients such as hormones for dental and orthopaedic applications.
• Leader BiomedicalcoreStrategic or Co-development PartnerCollaboration on Design & Development of NovoMem, an acellular resorbable collagen membrane processed with Leader Biomedical's proprietary eCOO® Technology. EMCM manufactures the membrane while Leader Biomedical is pursuing US FDA 510(k) registration based on substantial equivalence to predicate devices for the dental market.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Vetter Pharma: German-headquartered specialist aseptic fill-finish CDMO serving injectable pharmaceuticals, with deep expertise in vials, syringes and lyophilisation — directly comparable to EMCM's aseptic fill-finish offering, though Vetter operates at significantly greater scale.
• Aenova Group: European pharma contract manufacturer offering sterile and non-sterile production, fill-finish, and packaging for liquids, semisolids, and solids. Closely comparable to EMCM's broad CDMO service model and pharmaceutical customer base.
• Recipharm: Swedish-based full-service CDMO offering sterile fill-finish, lyophilisation, and GMP manufacturing across multiple dosage forms for pharma and biotech customers — comparable service portfolio and European mid-market CDMO positioning.
• Fareva: French pharmaceutical and cosmetics contract manufacturer with sterile injectable capabilities and a European manufacturing footprint, serving similar mid-sized pharma customers with project-based contract manufacturing.
• Rottendorf Pharma: German CDMO specialising in solid and semi-solid dosage forms with GMP manufacturing and regulatory support — comparable in scale, geographic focus, and full-service pharma contract manufacturing orientation.
• Haupt Pharma: European contract manufacturer of sterile and non-sterile pharmaceutical forms with strong GMP credentials and a focus on small-to-mid batch production, directly comparable to EMCM's positioning.
• Phillips-Medisize (Molex): Global medical device and combination-product contract manufacturer with sterile packaging, drug-delivery device assembly, and fill-finish capability — comparable on the medical-device and combination-product side of EMCM's portfolio.

Broad incumbents

• Catalent: Global CDMO leader with extensive aseptic fill-finish, softgel, biologics and oral dose capabilities. Overlaps with EMCM on sterile fill-finish and lyophilisation, but operates at far greater scale and breadth.
• Lonza: Swiss global CDMO with biologics, small molecules, and cell & gene therapy services. Comparable regulatory and GMP pedigree, but with vastly greater scale, modality breadth, and global footprint than EMCM.

Others

• Leader Biomedical Group: EMCM's strategic partner on NovoMem and shares its Executive Director; comparable in tissue/biomaterial focus and regulatory pathway (CE/FDA) for collagen-based medical devices, making it both a partner and an adjacent operating peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutu.be/RC-u19Vmtek
• LinkedInlinkedin.com/company/emcm-european-medical-contract-manufacturing

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Medical Contract Manufacturing